How does BLEV.F's PB Ratio compare to its peers?

Insufficient data to calculate BLEV.F's Price-To-Book Ratio vs. peers for valuation analysis.

How does BLEV.F's PB Ratio compare vs other companies in the US Pharmaceuticals Industry?

Insufficient data to calculate BLEV.F's Price-To-Book Ratio vs. industry for valuation analysis.

What is BLEV.F's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate BLEV.F's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of BLEV.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate BLEV.F's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Beleave OTCPK:BLEV.F Stock Report

Last Price

US$0.000001

Market Cap

US$553.0

7D

0%

1Y

0%

Updated

26 Dec, 2024

Data

Company Financials

Beleave Inc.

OTCPK:BLEV.F Stock Report

Market Cap: US$553.0

BLEV.F Stock Overview

Operates as a medical cannabis company in Canada. More details

BLEV.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($553)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Beleave Inc. Competitors

Hero Technologies

OTCPK:HENC

US$563.0

Item 9 Labs

OTCPK:INLB

US$701.0

Lucy Scientific Discovery

OTCPK:LSDI.F

US$882.0

BZAM

OTCPK:BZAM.F

US$270.0

Price History & Performance

Summary of share price highs, lows and changes for Beleave
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0024
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	0%
5 Year Change	-100.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BLEV.F	US Pharmaceuticals	US Market
7D	0%	2.9%	2.8%
1Y	0%	8.8%	24.5%

Return vs Industry: BLEV.F underperformed the US Pharmaceuticals industry which returned 10% over the past year.

Return vs Market: BLEV.F underperformed the US Market which returned 24.8% over the past year.

Price Volatility

Is BLEV.F's price volatile compared to industry and market?
BLEV.F volatility
BLEV.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.1%
10% least volatile stocks in US Market	3.1%

Stable Share Price: BLEV.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine BLEV.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Bill Panagiotakopoulos	beleave.com

Beleave Inc. operates as a medical cannabis company in Canada. The company cultivates and sells medical and recreational cannabis products. It also operates a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.

Beleave Inc. Fundamentals Summary

How do Beleave's earnings and revenue compare to its market cap?
BLEV.F fundamental statistics
Market cap	US$553.00
Earnings (TTM)	-US$11.48m
Revenue (TTM)	US$2.02m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is BLEV.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BLEV.F income statement (TTM)
Revenue	CA$2.90m
Cost of Revenue	CA$6.71m
Gross Profit	-CA$3.82m
Other Expenses	CA$12.68m
Earnings	-CA$16.49m

Last Reported Earnings

Dec 31, 2019

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did BLEV.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 03:05
End of Day Share Price	2024/12/24 00:00
Earnings	2019/12/31
Annual Earnings	2019/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beleave Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Daniel Pearlstein	Eight Capital
Siddharth Rajeev	Fundamental Research Corp.